Alexander Yakobson Selected Research

Alexander Yakobson Research Topics

Disease

15	Neoplasms (Cancer) 01/2024 - 08/2020
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 08/2020
7	Melanoma (Melanoma, Malignant) 01/2023 - 01/2019
4	Neoplasm Metastasis (Metastasis) 01/2023 - 05/2020
3	Adenocarcinoma of Lung 01/2024 - 07/2021
3	Adenocarcinoma 01/2024 - 07/2023
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2023 - 07/2023
3	Myocarditis (Carditis) 11/2023 - 05/2020
2	Bullous Pemphigoid (Pemphigoid) 09/2023 - 11/2022
2	Carcinoma (Carcinomatosis) 01/2023 - 07/2021
2	Nausea 01/2022 - 01/2022
1	Arteritis 11/2023
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2023
1	Autoimmune Diseases (Autoimmune Disease) 09/2023
1	Carpal Tunnel Syndrome 08/2023
1	Myasthenia Gravis 07/2023
1	Myxoma (Myxomas) 07/2023
1	Hyperbilirubinemia 01/2023
1	Merkel Cell Carcinoma 01/2023
1	COVID-19 01/2022
1	Fatigue 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Diarrhea 01/2022
1	Liposarcoma 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Breast Neoplasms (Breast Cancer) 11/2021
1	Neutropenia 11/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2021
1	Dyspnea (Shortness of Breath) 11/2021
1	Triple Negative Breast Neoplasms 11/2021
1	Pericarditis 10/2021
1	Takotsubo Cardiomyopathy 10/2021
1	Cardiotoxicity 10/2021
1	Malignant Mesothelioma 07/2021
1	Disease Progression 07/2021
1	Edema (Dropsy) 01/2021
1	Shock 01/2021
1	Epithelioid Hemangioendothelioma 01/2021
1	Capillary Leak Syndrome 01/2021
1	Hemangioma (Angioma) 01/2021
1	Hypercalcemia (Milk Alkali Syndrome) 03/2020
1	medullary Thyroid cancer 03/2020
1	Medulloblastoma 01/2020
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2019

Drug/Important Bio-Agent (IBA)

13	Immune Checkpoint InhibitorsIBA 01/2024 - 05/2020
5	NivolumabIBA 01/2024 - 01/2019
5	pembrolizumabIBA 07/2023 - 05/2020
3	IpilimumabIBA 01/2024 - 05/2020
2	PlatinumIBA 11/2023 - 03/2023
2	Tyrosine Kinase InhibitorsIBA 09/2023 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2021
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022 - 01/2021
1	AntibodiesIBA 01/2024
1	cemiplimabIBA 11/2023
1	SteroidsIBA 11/2023
1	Imatinib Mesylate (Gleevec)FDA Link 09/2023
1	avelumabIBA 01/2023
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2023
1	dabrafenibIBA 01/2023
1	trametinibIBA 01/2023
1	erdafitinibIBA 01/2023
1	BilirubinIBA 01/2023
1	Monoclonal AntibodiesIBA 11/2022
1	Biomarkers (Surrogate Marker)IBA 10/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	mobocertinibIBA 01/2022
1	selinexorIBA 01/2022
1	CrizotinibIBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	alectinibIBA 12/2021
1	Alkaline PhosphataseIBA 12/2021
1	Anaplastic Lymphoma KinaseIBA 12/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021
1	lenvatinibIBA 07/2021
1	pazopanib FDA Link 01/2021
1	B7-H1 AntigenIBA 08/2020
1	selpercatinibIBA 03/2020
1	HhAntag691IBA 01/2020

Therapy/Procedure

10	Therapeutics 01/2024 - 05/2020
7	Immunotherapy 01/2024 - 01/2019
7	Drug Therapy (Chemotherapy) 11/2023 - 01/2020
2	Salvage Therapy 01/2021 - 01/2020
1	Prostatectomy (Retropubic Prostatectomy) 10/2023
1	Radiotherapy 07/2023
1	Adjuvant Chemotherapy 11/2021
1	Neoadjuvant Therapy 11/2021